C07J 9/00
Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17
Official title: Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
C07J9/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17) appears on 1,213 US grants and 1,056 published applications in this corpus.
Search patents in C07J- Granted patents
- 1,213
- Published applications
- 1,056
- Assignees
- 650
- Inventors
- 2,784
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 22 | 0 |
| 1978 | 20 | 0 |
| 1979 | 21 | 0 |
| 1980 | 46 | 0 |
| 1981 | 35 | 0 |
| 1982 | 26 | 0 |
| 1983 | 16 | 0 |
| 1984 | 25 | 0 |
| 1985 | 13 | 0 |
| 1986 | 16 | 0 |
| 1987 | 14 | 0 |
| 1988 | 9 | 0 |
| 1989 | 17 | 0 |
| 1990 | 25 | 0 |
| 1991 | 16 | 0 |
| 1992 | 17 | 0 |
| 1993 | 19 | 0 |
| 1994 | 14 | 0 |
| 1995 | 27 | 0 |
| 1996 | 28 | 0 |
| 1997 | 29 | 0 |
| 1998 | 28 | 0 |
| 1999 | 13 | 0 |
| 2000 | 18 | 0 |
| 2001 | 24 | 6 |
| 2002 | 33 | 32 |
| 2003 | 19 | 28 |
| 2004 | 17 | 29 |
| 2005 | 15 | 38 |
| 2006 | 22 | 33 |
| 2007 | 9 | 25 |
| 2008 | 7 | 22 |
| 2009 | 7 | 22 |
| 2010 | 16 | 32 |
| 2011 | 16 | 29 |
| 2012 | 17 | 30 |
| 2013 | 24 | 37 |
| 2014 | 21 | 36 |
| 2015 | 29 | 40 |
| 2016 | 35 | 56 |
| 2017 | 39 | 78 |
| 2018 | 32 | 65 |
| 2019 | 61 | 71 |
| 2020 | 64 | 78 |
| 2021 | 58 | 66 |
| 2022 | 31 | 45 |
| 2023 | 27 | 44 |
| 2024 | 22 | 40 |
| 2025 | 21 | 41 |
| 2026 | 11 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Hyaluronic acid derivative, pharmaceutical composition, and hyaluronic acid derivative-drug complex15 Sep 2026US 12,735,513 B2Asahi Kasei Kabushiki Kaisha
- Oxysterol compounds and uses thereof25 Aug 2026US 12,715,893 B2Max Biopharma, Inc.
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Synthesis of cholesterol and vitamin D3 from phytosterols9 Jun 2026US 12,649,762 B2Fermenta Biotech Limited
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Oxysterols and methods of use thereof8 Oct 2026US 2026/0308197 A1Sage Therapeutics, Inc.
- Lipid nanoparticle compositions and uses thereof1 Oct 2026US 2026/0294935 A1Beijing Jitai Life Science Ltd
- Pharmaceuticl compositions comprising bile acid compounds for oral delivery of therapeutic peptides1 Oct 2026US 2026/0294936 A1Waterstone Pharmaceuticals(Wuhan) Co., Ltd.
- Lipids and nanoparticle formulations thereof1 Oct 2026US 2026/0295080 A1Arcturus Therapeutics, Inc.
Most cited
By later US patents
- Lipid formulations for nucleic acid delivery334US 8,058,069 B2Protiva Biotherapeutics, Inc. · 2011
- Method for delivering nucleic acids into cells278US 5,283,185 AMcMaster University · 1994
- Lipid formulations for nucleic acid delivery170US 9,364,435 B2Protiva Biotherapeutics, Inc. · 2016
- Use of a stanol fatty acid ester for reducing serum cholesterol level128US 5,502,045 ARaision Tehtaat Oy AB · 1996
- Estrogenic compounds as anti-angiogenic agents112US 5,504,074 AChildren's Medical Center Corporation · 1996